Research theme for competitive and other funds (7):
2023 - 2026 新規コリントランスポーター類の分子機能と生理的及び薬物動態的役割
2023 - 2026 Elucidation of substrate recognition mechanism of SLC19A3 to establish the molecular basis for medical applications
2022 - 2025 Elucidation of pyridoxine kinetics mediated by crosstalk between a novel pyridoxine transporter and ion channels/transporters
2020 - 2023 新規ポリアミントランスポーターの機能及び生理的役割の解明
2020 - 2023 Elucidation of molecular mechanism that triggers onset of gout from hyperuricemia
2021 - 2023 Elucidation of molecular mechanism of substrate-dependent transport function of SLC19A3 and its relevance to pathology
2019 - 2021 Elucidation of the molecular mechanism of intestinal absorption of pyridoxine and its application to therapeutic strategy for cancer
Show all
Papers (12):
Shogo Akino, Tomoya Yasujima, Rei Shibutani, Takahiro Yamashiro, Hiroaki Yuasa. Involvement of Proton-Coupled SLC49A4-Mediated Transport in the Export of Lysosomally Trapped Pyrilamine. Drug Metabolism and Disposition. 2024. 52. 1. 19-25
Shogo Akino, Tomoya Yasujima, Takahiro Yamashiro, Hiroaki Yuasa. Disrupted in renal carcinoma 2 (DIRC2/SLC49A4) is an H+-driven lysosomal pyridoxine exporter. Life science alliance. 2023. 6. 2. e202201629
Kohei Miyake, Tomoya Yasujima, Syunsuke Takahashi, Takahiro Yamashiro, Hiroaki Yuasa. Identification of the amino acid residues involved in the species-dependent differences in the pyridoxine transport function of SLC19A3. Journal of Biological Chemistry. 2022. 298. 8. 102161-102161
Takahiro Yamashiro, Tomoya Yasujima, Hiroaki Yuasa. Animal species differences in the pyridoxine transport function of SLC19A3: Absence of Slc19a3-mediated pyridoxine uptake in the rat small intestine. Drug Metabolism and Pharmacokinetics. 2022. 44. 100456-100456
Yutaro Shinoda, Takahiro Yamashiro, Akira Hosooka, Tomoya Yasujima, Hiroaki Yuasa. Functional characterization of human organic anion transporter 10 (OAT10/SLC22A13) as an orotate transporter. Drug Metabolism and Pharmacokinetics. 2022. 43. 100443-100443